单次视空间任务干预预防分娩相关创伤后应激障碍的多中心双盲随机对照试验
本研究为多中心双盲优效性随机对照试验,纳入146名因非计划剖宫产且自感分娩创伤的产妇,随机分配至单次视空间任务干预组或注意安慰剂组。结果显示,干预组在产后6个月PCL-5总分及认知情绪改变、唤醒症状簇上显著优于对照组,但CAPS-5未见组间差异;产后6周仅见边缘显著效应。
要点
- 单次视空间任务干预由受训产科临床人员实施,可预防分娩相关PTSD症状至产后6个月。
- 产后6个月PCL-5总分干预效应显著(β=-0.65,95%CI[-1.27,-0.03],p=0.041)。
- CAPS-5评估未发现组间差异,提示自评与临床评估结果不一致。
核心结论
- 单次视空间任务干预可预防分娩相关PTSD症状发展至产后6个月,但临床评估CAPS-5未见组间差异。
研究设计与样本
- 多中心、双盲、优效性随机对照试验,纳入146名非计划剖宫产且自感分娩创伤的产妇,按1:1随机分配至干预组(n=74)或注意安慰剂组(n=72),意图治疗分析。
主要发现
- 产后6周PCL-5总分边缘显著(β=-0.43,p<0.06),侵入症状(β=-0.73,p<0.0525)和唤醒症状(β=-0.55,p<0.0552)亦边缘显著。
- 产后6个月PCL-5总分显著(β=-0.65,95%CI[-1.27,-0.03],p=0.041),认知情绪改变(β=-0.85,p=0.0016)和唤醒症状(β=-0.56,95%CI[-1.07,-0.06],p<0.0289)显著。
- CAPS-5评估未发现组间差异。
关键数值与推荐
- 主要结局为产后6周PCL-5评估的PTSD症状,次要结局为产后6个月PCL-5和CAPS-5评估。
- 干预为单次视空间任务程序,由受训产科临床人员实施。
临床怎么用
- 对于非计划剖宫产且自感分娩创伤的产妇,可考虑在产后早期提供单次视空间任务干预以预防PTSD症状。
- 干预可由受训产科临床人员实施,具有较好的可推广性。
局限性
- 产后6周主要结局仅边缘显著,未达到传统显著性水平。
- CAPS-5未显示组间差异,自评与临床评估结果不一致。
- 样本量较小(146例),可能影响统计效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preventive evidence-based interventions for childbirth-related posttraumatic stress disorder (CB-PTSD) are lacking. Yet, 18.5% of women develop CB-PTSD symptoms following an unplanned caesarean section (UCS). This two-arm, multicentre, double-blind superiority trial tested the efficacy of an early single-session intervention including a visuospatial task on the prevention of maternal CB-PTSD symptoms. The intervention was delivered by trained maternity clinicians. Shortly after UCS, women were included if they gave birth to a live baby, provided consent, and perceived their childbirth as traumatic. Participants were randomly assigned to the intervention or attention-placebo group (allocation ratio 1:1). Assessments were done at birth, six weeks, and six months postpartum. Group differences in maternal CB-PTSD symptoms at six weeks (primary outcomes) and six months postpartum (secondary outcomes) were assessed with the self-report PTSD Checklist for DSM-5 (PCL-5) and by blinded research assessors with the Clinician-administered PTSD scale for DSM-5 (CAPS-5). Analysis was by intention-to-treat. The trial was prospectively registered (ClinicalTrials.gov, NCT03576586). Of the 2068 women assessed for eligibility, 166 were eligible and 146 were randomly assigned to the intervention (n = 74) or attention-placebo control group (n = 72). For the PCL-5, at six weeks, a marginally significant intervention effect was found on the total PCL-5 PTSD symptom count (β = -0.43, S.E. = 0.23, z = -1.88, p < 0.06), and on the intrusions (β = -0.73, S.E. = 0.38, z = -1.94, p < 0.0525) and arousal (β = -0.55, S.E. = 0.29, z = -1.92, p < 0.0552) clusters. At six months, a significant intervention effect on the total PCL-5 PTSD symptom count (β = -0.65, S.E. = 0.32, z = -2.04, p = 0.041, 95%CI[-1.27, -0.03]), on alterations in cognition and mood (β = -0.85, S.E. = 0.27, z = -3.15, p = 0.0016) and arousal (β = -0.56, S.E. = 0.26, z = -2.19, p < 0.0289, 95%CI[-1.07, -0.06]) clusters appeared. No group differences on the CAPS-5 emerged. Results provide evidence that this brief, single-session intervention carried out by trained clinicians can prevent the development of CB-PTSD symptoms up to six months postpartum.
引用
- Deforges C, Sandoz V, Noël Y, et al. Single-session visuospatial task procedure to prevent childbirth-related posttraumatic stress disorder: a multicentre double-blind randomised controlled trial. Mol Psychiatry. 2023. PMID: 37759037. doi:10.1038/s41380-023-02275-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。